Advertisement
  • Loading metrics

Common Genetic Variation and the Control of HIV-1 in Humans

  • Jacques Fellay ,

    Contributed equally to this work with: Jacques Fellay, Dongliang Ge

    Affiliation Center for Human Genome Variation, Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  • Dongliang Ge ,

    Contributed equally to this work with: Jacques Fellay, Dongliang Ge

    Affiliation Center for Human Genome Variation, Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  • Kevin V. Shianna,

    Affiliations Center for Human Genome Variation, Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America, Genomic Analysis Facility, Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  • Sara Colombo,

    Affiliation Institute of Microbiology, University of Lausanne, Lausanne, Switzerland

  • Bruno Ledergerber,

    Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital, University of Zürich, Zürich, Switzerland

  • Elizabeth T. Cirulli,

    Affiliation Center for Human Genome Variation, Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  • Thomas J. Urban,

    Affiliation Center for Human Genome Variation, Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  • Kunlin Zhang,

    Affiliations Institute of Microbiology, University of Lausanne, Lausanne, Switzerland, Behavioral Genetics Center, Institute of Psychology, Chinese Academy of Sciences, Beijing, China

  • Curtis E. Gumbs,

    Affiliation Center for Human Genome Variation, Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  • Jason P. Smith,

    Affiliation Genomic Analysis Facility, Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  • Antonella Castagna,

    Affiliation Clinic of Infectious Diseases, Vita-Salute San Raffaele University and Diagnostica and Ricerca San Raffaele, Milan, Italy

  • Alessandro Cozzi-Lepri,

    Affiliation Research Department of Infection and Population Health, University College London, London, United Kingdom

  • Andrea De Luca,

    Affiliation Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy

  • Philippa Easterbrook,

    Affiliation Academic Department of HIV/GUM, Kings College London at Guy's, King's, and St. Thomas' Hospitals, Weston Education Centre, London, United Kingdom

  • Huldrych F. Günthard,

    Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital, University of Zürich, Zürich, Switzerland

  • Simon Mallal,

    Affiliation Centre for Clinical Immunology and Biomedical Statistics, Institute for Immunology and Infectious Diseases, Royal Perth Hospital and Murdoch University, Perth, Australia

  • Cristina Mussini,

    Affiliation Infectious Diseases Clinics, Azienda Ospedaliero-Universitaria, Modena, Italy

  • Judith Dalmau,

    Affiliation IrsiCaixa Foundation and Hospital Germans Trias i Pujol, Badalona, Spain

  • Javier Martinez-Picado,

    Affiliations IrsiCaixa Foundation and Hospital Germans Trias i Pujol, Badalona, Spain, Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

  • José M. Miro,

    Affiliation Hospital Clinic – IDIBAPS, University of Barcelona, Barcelona, Spain

  • Niels Obel,

    Affiliation Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

  • Steven M. Wolinsky,

    Affiliation Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America

  • Jeremy J. Martinson,

    Affiliation Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  • Roger Detels,

    Affiliation Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  • Joseph B. Margolick,

    Affiliation Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  • Lisa P. Jacobson,

    Affiliation Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  • Patrick Descombes,

    Affiliation Genomics Platform, National Centre of Competence in Research “Frontiers in Genetics,” University of Geneva, Geneva, Switzerland

  • Stylianos E. Antonarakis,

    Affiliation Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland

  • Jacques S. Beckmann,

    Affiliation Department of Medical Genetics, University of Lausanne, and Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

  • Stephen J. O'Brien,

    Affiliation Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland, United States of America

  • Norman L. Letvin,

    Affiliation Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America

  • Andrew J. McMichael,

    Affiliation MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom

  • Barton F. Haynes,

    Affiliation Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America

  • Mary Carrington,

    Affiliations Cancer and Inflammation Program, Laboratory of Experimental Immunology, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, United States of America, Ragon Institute of Massachusetts General Hospital, MIT and Harvard, Boston, Massachusetts, United States of America

  • Sheng Feng,

    Affiliation Center for Human Genome Variation, Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  • Amalio Telenti ,

    d.goldstein@duke.edu (DBG); amalio.telenti@chuv.ch (AT)

    Affiliation Institute of Microbiology, University of Lausanne, Lausanne, Switzerland

  • David B. Goldstein ,

    d.goldstein@duke.edu (DBG); amalio.telenti@chuv.ch (AT)

    Affiliation Center for Human Genome Variation, Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America

  •  [ ... ],
  • NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI)
  • [ view all ]
  • [ view less ]

Common Genetic Variation and the Control of HIV-1 in Humans

  • Jacques Fellay, 
  • Dongliang Ge, 
  • Kevin V. Shianna, 
  • Sara Colombo, 
  • Bruno Ledergerber, 
  • Elizabeth T. Cirulli, 
  • Thomas J. Urban, 
  • Kunlin Zhang, 
  • Curtis E. Gumbs, 
  • Jason P. Smith
PLOS
x

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.